Earnings ·
Elevance reaffirms full-year 2026 adjusted earnings guidance of at least $29.00 per diluted share
ELVElevance Health, Inc.
Elevance Health officers will speak with investors this week to reaffirm the company's full-year 2026 shareholders' earnings guidance. The company expects earnings of at least $22.00 per diluted share, which includes approximately $7.00 per diluted share in net unfavorable items. Excluding these specific items, adjusted shareholders' earnings are expected to be at least $29.00 per diluted share. Additionally, the company reaffirmed its full-year 2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points. This update does not include any other adjustment items beyond those reported in the third quarter 2026 earnings. Elevance Health operates as a managed care organization providing health insurance and related services.